Evaluation of treatment satisfaction in children with allergic disease treated with an antihistamine: An international, non-interventional, retrospective study

Clinical Drug Investigation

Volumn 30, Issue 1, 2010, Pages 15-34

  Ferrer, Marta ^a   Morais Almeida, Mário ^b   Guizova, Margarita ^c   Khanferyan, Roman ^d  

^a UNIVERSITY CLINIC OF NAVARRA   (Spain)

^b Hospital CUF Descobertas   (Portugal)

^c UNIVERSITY HOSPITAL ALEXANDROVSKA   (Bulgaria)

^d KUBAN STATE MEDICAL UNIVERSITY   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; AZELASTINE; CETIRIZINE; CHLORPHENIRAMINE; CLEMASTINE; CYPROHEPTADINE; DESLORATADINE; DIPHENHYDRAMINE; FEXOFENADINE; HYDROXYZINE; LEVOCETIRIZINE; LORATADINE; PROMETHAZINE;

ABSENCE OF SIDE EFFECTS; ACADEMIC ACHIEVEMENT; ALLERGIC RHINITIS; ALLERGY; ARTICLE; ASTHMA; ATOPIC DERMATITIS; CHILD; CONSULTATION; CONTROLLED STUDY; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG TOLERABILITY; FEMALE; FOOD ALLERGY; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PARENTAL ATTITUDE; PATIENT SATISFACTION; PHYSICIAN ATTITUDE; PRESCHOOL CHILD; PRIORITY JOURNAL; QUESTIONNAIRE; RETROSPECTIVE STUDY; SCHOOL CHILD; SLEEP; SOMNOLENCE; UNSPECIFIED SIDE EFFECT; URTICARIA;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; FEMALE; HISTAMINE ANTAGONISTS; HUMANS; HYPERSENSITIVITY; INFANT; MALE; PATIENT SATISFACTION; QUALITY OF LIFE; RETROSPECTIVE STUDIES;

EID: 72049113595     PISSN: 11732563     EISSN: 11791918     Source Type: Journal    
DOI: 10.2165/11530910-000000000-00000     Document Type: Article

References (31)

1. Eigenmann PA, Antonella Muraro M, Sampson HA, et al. iPAC: an initiative to fight the burden of allergies in children. Pediatr Allergy Immunol 2008; 19 Suppl. 19: 1-3
2. Hamelmann E, Herz U, Holt P, et al. New visions for basic research and primary prevention of pediatric allergy: an iPAC summary and future trends. Pediatr Allergy Immunol 2008; 19 Suppl. 19: 4-16
3. Halken S, Lau S, Valovirta E. New visions in specific immunotherapy in children: an iPAC summary and future trends. Pediatr Allergy Immunol 2008; 19 Suppl. 19: 60-70
4. Eigenmann PA, Beyer K, Burks AW, et al. New visions for food allergy: an iPAC summary and future trends. Pediatr Allergy Immunol 2008; 19 Suppl. 19: 26-39
5. Rancé F, Boguniewicz M, Lau S. New visions for atopic eczema: an iPAC summary and future trends. Pediatr Allergy Immunol 2008; 19 Suppl. 19: 17-25
6. Baiardini I, Braido F, Tarantini F, et al. ARIA-suggested drugs for allergic rhinitis: what impact on quality of life? A GA2LEN review. Allergy 2008; 63 (6): 660-669
7. Baiardini I, Braido F, Brandi S, et al. The impact of GINA suggested drugs for the treatment of asthma on healthrelated quality of life: a GA2LEN review. Allergy 2008; 63 (8): 1015-1030
8. Passalacqua G, Canonica GW, Baiardini I. Rhinitis, rhinosinusitis and quality of life in children. Pediatr Allergy Immunol 2007; 18 Suppl. 18: 40-45
9. Bousquet J, Reid J, Van Weel C, et al. Allergic rhinitis management pocket reference 2008. Allergy 2008; 63 (8): 990-996
10. vanWeel C, Bateman ED, Bousquet J, et al. Asthma management pocket reference 2008. Allergy 2008; 63 (8): 997-1004
11. Zuberbier T, Bindslev-Jensen C, Canonica W, et al. EAACI/ GA2LEN/EDF guideline: management of urticaria. Allergy 2006; 61 (3): 321-331
12. De Vos C,Mitchev K, Pinelli M-E, et al. Non-interventional study comparing treatment satisfaction in patients treated with antihistamines. Clin Drug Invest 2008; 28: 221-230
13. Holgate ST, Canonica GW, Simons FE, et al. Consensus group on new-generation antihistamines (CONGA): present status and recommendations. Clin Exp Allergy 2003; 33: 1305-1324
14. Molimard M, Diquet B, Strolin Beneditti M. Comparison of pharmacokinetics and metabolism of desloratadine, fexofenadine, levocetirizine and mizolastine in humans. Fund Clin Pharmacol 2004; 18: 399-411
15. Tillement J-P, Albengres E, Barré L, et al. The apparent volumes of distribution of H1-receptor antagonists. Dermatol Ther 2000; 13: 337-343
16. Simons FE, Early Prevention of Asthma in Atopic Children (EPAAC) Study Group. H1-antihistamine treatment in young atopic children: effect on urticaria. Ann Allergy Asthma Immunol 2007; 99: 261-266
17. Simons FE, Early Prevention of Asthma in Atopic Children (EPAAC) Study Group. Safety of levocetirizine treatment in young atopic children: an 18-month study. Pediatr Allergy Immunol 2007b; 18 (6): 535-542
18. Asarnoj A, Ostblom E, Kull I, et al. Sensitization to inhalant allergens between 4 and 8 years of age is a dynamic process: results from the BAMSE birth cohort. Clin Exp Allergy 2008; 38 (9): 1507-1513
19. Linneberg A. The allergic march in early childhood and beyond. Clin Exp Allergy 2008; 38 (9): 1419-1421
20. De Blic J, Wahn U, Billard E, et al. Levocetirizine in children: evidenced efficacy and safety in a six-week, randomised seasonal allergic rhinitis trial. Pediatr Allergy Immunol 2005; 16: 267-275
21. Potter PC. Efficacy and safety of levocetirizine on symptoms and health-related quality of life of children with perennial allergic rhinitis: a double blind placebo controlled randomized clinical trial. Ann Allergy Asthma Immunol 2005; 95: 175-180
22. Bloom M, Staudinger H, Herron J. Safety of desloratadine syrup in children. Curr Med Res Opin 2004; 20 (12): 1959-1965
23. Milgrom H, Kittner B, Lanier R, et al. Safety and tolerability of fexofenadine for the treatment of allergic rhinitis in children 2 to 5 years old. Ann Allergy Asthma Immunol 2007; 99 (4): 358-363
24. Wahn U, Meltzer EO, Finn Jr AF, et al. Fexofenadine is efficacious and safe in children (aged 6-11 years) with seasonal allergic rhinitis. J Allergy Clin Immunol 2003; 111 (4): 763-769
25. Beno SM, Nadel FM, Alessandrini EA. A survey of emergency department management of acute urticaria in children. Pediatr Emerg Care 2007; 23 (12): 862-868
26. Liu H, Zheng Q, Farley JM. Antimuscarinic actions of antihistamines on the heart. J Biomed Sci 2006; 13 (3): 395-401
27. Ferrer M, Já uregui I, Bartra J, et al. Chronic urticaria: do urticaria nonexperts implement treatment guidelines? A survey of adherence to published guidelines by nonexperts. Br J Dermatol 2009; 160 (4): 823-827
28. Deacock SJ. An approach to the patient with urticaria. Clin Exp Immunol 2008; 153 (2): 151-161
29. Patel T, Ishiuji Y, Yosipovitch G. Nocturnal itch: why do we itch at night? Acta Derm Venereol 2007; 87 (4): 295-298
30. Boyle J, Eriksson M, Stanley N, et al. Allergy medication in Japanese volunteers: treatment effect of single doses on nocturnal sleep architecture and next day residual effects. Curr Med Res Opin 2006; 22 (7): 1343-1351
31. Singer AJ, Thode Jr HC. Determination of the minimal clinically significant difference on a patient visual analog satisfaction scale. Acad Emerg Med 1998; 5 (10): 1007-1011